Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
Clinical trial NCT05676450 · RECRUITING
Trial details
- NCT number
- NCT05676450
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2026-08-31
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.